Goldman Sachs Reiterates Buy Rating on Broadcom (AVGO) Stock

The index on Wednesday tallied its first intraday and closing record highs since the start of the Iran conflict.

Portal Innovations CEO John Flavin provides a look into the 2026 biotech M&A pipeline and breaks down Eli Lilly’s purported acquisition of CrossBridge Bio for up to $300 million, bolstering its oncology segment. He talks with Katie Greifeld and Romaine Bostick on “The Close.” (Source: Bloomberg)

The departure was announced alongside Ford detailing a new restructuring that includes the establishment of a "Product Creation and Industrialization" unit.

Goldman's identity as a trader's firm — one expected to perform in turbulent markets — makes any stumble in the division notable.